Invitae Corporation (NYSE:NVTA) entered into a stock purchase agreement to acquire Jungla Inc. from Andreessen Horowitz LLC and others.

Jungla Inc. develops molecular function software platform for healthcare and drug companies to optimize disease diagnosis.